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Abstract The focus of this review is placed on the chemical structures from the species of the genus Talaromyces
reported with reference to their biological activities. 221 secondary metabolites, including 43 alkaloids and peptides, 88
esters, 31 polyketides, 19 quinones, 15 steroid and terpenoids, and 25 other structure type compounds, have been included,
and 66 references are cited.
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1 Introduction
The name Talaromyces is derived from the Greek word for
‘basket’, which aptly describes the body in which ascos-
pores are formed. In the past, species producing sexual
stages with Penicillium anamorphs have been classified in
Eupenicillium and Talaromyces. After July 2011, species
formally classified in the Penicillium subgenus Biverticil-
lium were classified in Talaromyces. The situation is
complicated by the fact that many species now classified in
Talaromyces will continue to be sought as Penicillium
species in identifications [1]. So in this review, all of the
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papers which reported the secondary metabolites from the
species named Talaromyces were covered.
The genus Talaromyces (Trichocomaceae) is an important
fungal genus because of its ubiquity which were isolated from
soil, plants, sponges, and foods. Some of the species are heat
resistant. Some of the species are famous because of their
enzymes applicable in the synthesis of saccharides, prepara-
tion of chiral building blocks or biotransformations, and for its
application in pest biocontrol. Many of its species are used in
food and agricultural production. Interestingly, the T. pino-
philus strain EMOO 13–3 is able to degrade agricultural waste
[2]. However, although endemic in maize, T. funiculosus also
occurs in a wide range of other foods and sometimes causes
spoilage [1]. Considering their importance, members of this
genus have attracted the attention of chemists. Many studies
have focused on the secondary metabolites.
2 The Secondary Metabolites
The secondary metabolites of Talaromyces mainly include
alkaloids, peptides, lactones, polyketides, and miscella-
neous structure type compounds. T. flavus, a microorgan-
ism remarkable for its secondary metabolites with unique
biological activities, is the commonest species of the genus
Talaromyces [3]. All of the natural products from the
species of this genus are classified. The reported bioac-
tivities are also represented below.
2.1 Alkaloids and Peptides
Alkaloid is a kind of important natural products.
Many alkaloids have various kinds of biological activ-
ities, such as antibacterial, antifungal, cytotoxic, and
nematicidal. The structures of alkaloids isolated from
Talaromyces species are mainly nitrogen heterocyclic
derivatives.
Two prenylated indole alkaloids, talathermophilins A
and B (1 and 2), were isolated from a thermophilic
fungus T. thermophilus strain YM1-3. And the ratio of 1
and 2 in the culture broths was unexpectedly rather
constant (about 2:3), which even remained unchanged
despite the addition of exogenous 1 or 2 suggesting that
talathermophilins might be of special function for the
extremophilic fungus. Those both compounds showed
nematicidal toxicity (ca. 38 and 44 % inhibition,
respectively) toward the worms of the free-living
nematode Panagrellus redivivus at a concentration of
400 lg/mL for 72 h. The family of prenylated indole
alkaloids is a well-known group of secondary metabo-
lites mainly produced by Aspergillus and Penicillium sp.
This is a first report about pyranoindol alkaloids from
Talaromyces [4]. Other fourindole alkaloids with various
levels of prenylation, talathermophilins C–E (3–5) and
cyclo (glycyltryptophyl) (6), from the thermophilic fun-
gus T. thermophilus strain YM3-4 which was collected
in hot springs, were also elucidated by the same research
group in 2011 [5]. Interestingly, authors found that only
a very small group of amino acids (glycine, alanine,
proline, and its derivatives) could be naturally chosen as
a starting building block to form the 2,5-diketopiper-
azine with tryptophan [4, 5].
Seven known indole alkaloids (7–12) were obtained
from the culture of the alga-endophytic fungus Talar-
omyces sp. cf-16. Bioassay results showed that 9 was more
toxic to brine shrimp than the other compounds, and 8, 9,
and 10 could inhibit Staphylococcus aureus [6].
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Three known diketopiperazines, cyclo(L-proline-L-leu-
cine) (13), cyclo(L-proline-L-phenylalanine) (14), and
cyclo(L-tyrosine-L-phenylalanine) (15), were isolated from
the methanolic extracts of the green Chinese onion-derived
fungus T. pinophilus AF-02 [7].
An unprecedented class of PKS-NRPS hybrid metabo-
lites possessing a 13-membered lactam-bearing macrolac-
tone, thermolides A–F (16–21), were also obtained from T.
thermophilus YM3-4. They showed that compounds 16 and
17 displayed potent inhibitory activity against three noto-
rious nematodes with LC50 values of 0.5–1 lg/mL, as
active as commercial avermectins. This is the first report on
the discovery of hybrid macrolides from a fungus origin
[8]. Afterwards, a combination of chemical screening,
genome analyses, and genetic manipulation led to the
identification of the thermolide biosynthetic genes from
sister thermophilic fungi T. thermophilus and Thermomyces
lanuginosus C5. And a novel macrolactone, thermolide G
(22), was obtained from the cultural broth of Thermomyces
lanuginosus C5. Their results revealed the first fungal
hybrid iterative polyketide synthase–nonribosomal peptide
synthetase (PKS–NRPS) genes involved in the biosynthesis
of bacterial-like hybrid macrolactones instead of typical
fungal tetramic acids-containing metabolites [9].
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Four new tetramic acid derivatives, talaroconvolutins
A–D (23–26), along with a known mitorubrin derivative,
ZG-1494R (27), were isolated from the strain T. convolutes
by the group of Shun-ichi Udagawa in 2000. The antifungal
activity of the talaroconvolutins against the pathogenic
fungi Aspergillus fumigates, A. niger, Cryptococcus albi-
cans, and C. neoformans, was determined. And the results
showed that talaroconvolutins B (24) and C (25) and ZG-
1494R (27) inhibited the growth of A. fumigatus, A. niger,
and C. albicans [10].
Four new drimane sesquiterpene lactones conjugated
with N-acetyl-L-valine, minioluteumides A–D (28–31), and
three known compounds, purpuride (32), berkedrimane B
(33), and purpuride B (34), were isolated from the marine
fungus, T. minioluteus (P. minioluteum) by the group of
Prasat Kittakoop. The structure 28 was elucidated by single
crystal X-ray analysis. 28, 31 and 33 showed cytotoxic
activity against HepG2 with IC50 ranges of 50.6–193.3 lM,
but 28–34 did not shown any inhibit activity to caspase-3
[11].
A peptide analogue N-benzoylphenylalanyl-N-ben-
zoylphenylalaninate (35) was isolated from the fungus T.
thailandiasis, which was firstly found from a higher plant,
Croton hieronymi [12]. Two new cyclic peptides, talaromins
A and B (36 and 37) were yielded from the endophytic
fungus T. wortmannii, isolated from Aloe vera by the group
of Peter Proksch and Abdessamad Debbab. Both cyclopep-
tides contain ring systems comprised of six a-amino acid
residues connected to b-amino acid. The absolute configu-
rations of the a-amino acids were determined by Marfey’s
method. Both compounds showed no activity when evalu-
ated for their cytotoxicity against L5178Y mouse lymphoma
cells and no antibacterial activity against a broad spectrum of
bacterial strains up to a concentration of 64 lg/mL [13].
9-(3-L-alanylamino-3-carboxypropyl)adenine (NK374200,
38) with a peptidyl adenine nucleus was isolated from the
culture broth of the fungus Talaromyces sp., which had been
isolated from a soil sample. 38 was screened in various
biological assay systems, and found to have anti-mosquito
larval activity [14].
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Two quinazoline alkaloids, 2-[(S)-hydroxy(phenyl)
methyl]-3-methylquinazolin-4(3H)-one (39) and 2-[(R)-
hydroxy(phenyl)methyl]-3-methylquinazolin-4(3H)-one (40),
and a pyridone derivative (41), were isolated and identified in
a culture of the alga-endophytic fungus Talaromyces sp.
cf-16 for the first time. Following chiral column chro-
matography, compounds 39 and 40 were identified as
enantiomers by spectroscopic analyses and quantum
chemical calculations [6].
(E)-3-(2,5-dioxo-3-(propan-2-ylidene)pyrrolidin-1-yl)
acrylic acid (42) was isolated from the ethyl acetate
extract of the culture broth of T. verruculosus, a rhizo-
sphere fungus of Stellera chamaejasme L.In the antimi-
crobial activities, 42 gave slight active against the plant
pathogenic fungi, Alternaria solani, Valsa mali, Curvu-
laria lunata, and Botryosphaeria berengeriana, at
100 lg/mL and its MIC values against pathogenic bac-
teria, Straphylococcus aureus and Escherichia coli, were
more than 100 lg/mL [15]. Emerin (43) was obtained
from the extract of T. flavus IFM52668, and showed no
activity against pathogenic filamentous fungi, Aspergil-
lus fumigatus and A. niger, and pathogenic yeasts,
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2.2 Esters
The secondary metabolites of Talaromyces are mainly
esters, including macrolides, linear polyesters, aromatic
lactones, coumarins, phthalides, and five/six-membered
saturated lactones.
Four novel 22-membered triene macrolides, wort-
mannilactones A–D (44–47), were obtained from the
fungus T. wortmannii which isolated from a soil sample
collected in China’s Yunnan province. 44–47 were
screened for cytotoxic activity against a panel of human
cancer cell lines (HCT-5, HCT-115, A549, MDA-MB-
231, and K562). The IC50 values range from 28.7 to
130.5 lM [17]. Vermiculine (48), a 16-membered mac-
rolide dilactone antibiotic had been found in crystalline
solid from T. wortmannii, isolated from a soil sample
[18].
Seven 15G256 macrolidepolyesters, 15G256i (49),
15G256b (50), 15G256a (51), talapolyester E (52), 15G256a-
1 (53), talapolyester F (54), and 15G256x (55), were isolated
from the wetland soil-derived fungus T. flavus BYD07-13 by
Chinese researchers. Among these compounds, 50 and 55
exhibited significant activity against MCF-7 cell line with the
IC50 of 3.27 and 4.32 lM, respectively [19]. 51 [20, 21] and
53 [22] were also isolated from the soil-derived fungus T.
flavus FKI-0076 by Japanese researchers. In the course of
screening for synergist effects with clinic-used miconazole as
well as antifungal agent, 51 was showed that can inhibit
Bacillus subtilis (IC50 15 mg/L), Staphyloccus aureus (IC50
90 mg/L), Micrococcus luteus (IC50 100 mg/L), Mucor-
racemosus (IC50 40 mg/L) [20]. As proposed by Schling-
mann, 15G256 polyesters are biosynthetically assembled by
alternately linking 2,4-dihydroxy-6-(2-hydroxypropyl)ben-
zoic acid and 3-hydroxybutyric acid moieties [23].
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Four new linear polyesters, talapolyesters A–D (56–
59), together with six known compounds (60–65),
were isolated from the wetland soil-derived fungus
T. flavus BYD07-13. Those compounds contained both
2,4-dihydroxy-6-(2-hydroxypropyl)benzoic acid or its
derivatives and 3-hydroxybutyric acid or its deriva-
tives. The cytotoxicity against five tumor cell lines of
those compounds was examined, but all polyesters
were inactive (IC50[ 40 lM) as compared to cisplatin
[19].
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Three new oxaphenalenone dimers, bacillosporins A–C
(66–68), were isolated from T. bacillosporus NHL 2660.
66 had the antibacterial activity against Bacillus subtilis
and Sarcina lutea [24]. Other oligophenalenone dimers,
bacillisporins D and E (69 and 70) and duclauxin (71),
were isolated from the fungus T. bacillisporus from a
soil sample. They were screened for in vitro cytotoxicity
again three human tumor cell lines MCF-7, NCI-H-460
and SF-268, and 71 exhibited moderate inhibitory effects
against all three cell lines but 70 showed little activity
[25]. In 2015, two new oxaphenalenone dimers, talar-
omycesone A (72) and talaromycesone B (73), were iso-
lated from the culture broth and mycelia of a marine
fungus Talaromyces sp. strain LF458. 72 exhibited potent
antibacterial activities with IC50 3.70 lM against human
pathogenic Staphylococcus strains, and 72 also displayed
potent acetylcholinesterase inhibitory activities with IC50
7.49 lM [26].
Antibacterial binaphtho-a-pyrones, talaroderxines A and
B (74 and 75) were isolated from a new heterothallic
ascomycetous fungus, T. derxii, cultivated on rice. The
antibacterial activities of the metabolites from T. derxii and
their derivations against Bacillus subtilis indicated that
only talaroderxine, the mixture of 74 and 75, showed
antibacterial activity, which was almost as strong as that
of viriditoxin. And talaroderxine had inhibitory activity
toward 5-lipoxygenase, its IC50 value was determined as
3.8 9 10-6 M [27].
Eight new dinapinones, AB1, AB2, AC1, AC2,
AD1, AD2, AE1 and AE2 (76–83) were obtained from
the culture broth of T. pinophilus FKI-3864. All
these dinapinones possessed the same biaryl dihy-
dronaphthopyranone skeleton consisting of a hetero-
dimer with one monapinone A and one different
monapinone. The effect of dinapinones was evaluated
on the synthesis of [14C] triacylglycerol (TG) and [14C]
cholesterol ester from [14C] oleic acid in CHO-K1
cells and the results indicated that dinapinone (77)
showed potent inhibition of TG synthesis in intact
mammalian cells with an IC50 value of 1.17 lM,
whereas the other dinapinones showed weak inhibition
of TG synthesis [28].
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Sixdiphenyl ether lactone derivatives (84, 85 and 86–88)
and AS-186c (89) were isolated from amarine fungus
Talaromyces sp. strain LF458. 89 exhibited potent antibac-
terial activities with IC50 1.34 lM against human pathogenic
Staphylococcus strains, potent acetylcholinesterase inhibi-
tory activities with IC502.60 lM, and phosphodiesterase
PDE-4B2 inhibitory activities with IC502.63 lM [26].
Penicillide and dehydroisopenicillide (84 and 85) were
isolated from T. derxii cultivated on rice [29]. Penicillide
was also isolated from the methanolic extracts of the green
Chinese onion-derived fungus T. pinophilus AF-02 [7].
A coumarin 90 was obtained from the organic extracts
of the soil fungus T. flavus [30]. Two new coumarins,
talacoumarins A (91) and B (92), were isolated from the
ethyl acetate extract of the wetland soil-derived fungus
T. flavus BYD07-13. They were evaluated for anti-Ab42
aggregation, cytotoxic, and antimicrobial activities and
the results showed that 91 and 92 had moderate anti-
Ab42 aggregation activity, and this was the first report
on the Ab42 inhibitory aggregation activity of coumarins
[31].
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An O-methylated 3,4-dihydroisocoumarin 93 was iso-
lated from a previously undescribed fungus T. thailandiasis
[12]. An isocoumarin derivate (94) was isolated from the
ethyl acetate extract of the culture broth of T. verruculosus,
a rhizosphere fungus of Stellera chamaejasme L. 94
exhibited the significant activities in vitro against Staphy-
lococcus aureus and Escherichia coli, with MIC values of
2.5 and 5.0 lg/mL, respectively. And for the plant patho-
genic fungi, 94 disclosed significant growth inhibitions of
92.6 ± 2.1, 97.3 ± 3.3, 87.2 ± 2.8 and 94.9 ± 1.9 % at
50 lg/mL against Alternaria solani, Valsa mali, Curvu-
laria lunata and Botryosphaeria berengeriana, respectively
[15]. Two isocoumarin derivates (95 and 96) were isolated
from the organic extracts of the soil fungus T. flavus [30].
Sclerotinin A (97) and alternariol (98) were isolated from
the methanolic extracts of the green Chinese onion-derived
fungus T. pinophilus AF-02 [7].
Merodrimanes, thailandolides A (99) and B (100), a dri-
mane linked through a tertiary oxygen to the dihydroiso-
coumarin, were isolated from a previously undescribed fungus
T. thailandiasis [12]. A new meroterpenoid, chrodrimanin C
(101) together with chrodrimanins A and B (102 and 103) from
the strain YO-2 of Talaromyces sp. Chrodrimanin B exhibited
insecticidal activity with an LD50 value of 10 lg/g of diet, while
chrodrimanins A and C were inactive [32]. Four new meroter-
penoids, named chrodrimanin D–G (104–107), and a known
compound chrodrimanin H (108) were also isolated from the
strain YO-2 of Talaromyces sp. Chrodrimanins D, E and F
(104–106) showed insecticidal activity against silkworms with
respective LD50 values of 20, 10 and 50 lg/g of diet [33].
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A phthalide derivative 109 and a spiro-phthalide
derivative 110 were obtained from the organic extracts and
from the water extracts of the soil fungus T. flavus [30, 34].
Another phthalide compound FKI-0076 B, vermistatin 111,
was obtained from Talaromyces sp. during the screening
programme for synergist of azoles antifungal antibiotics
[20]. 111 was also isolated from the extract of T. flavus
IFM52668 [16], and from the culture broth T. flavus FKI-
0076 which isolated from a soil sample [21]. Other two
analogues penisimplicissin (112) and hydroxydihydrover-
mistatin (113) were isolated from the fungus T. thailandi-
asis [12].
Three new phthalide derivatives, talaromycolides A–C
(114–116), and a known compound rubralide C (117), were
isolated from the methanolic extracts of the green Chinese
onion-derived fungus T. pinophilus AF-02. Talaromycol-
ides A–C are rare phthalide derivatives with a novel link-
age position between the phenyl and phthalide moieties,
and exhibited significant antibacterial activity in response
to some of the tested strains, Bacillus subtilis, B. mega-
terium, Escherichia coli, Clostridium perfringens, Micro-
coccus tetragenus, and no activity against the strain of
MRSA (methicillin-resistant Staphylococcus aureus) [7].
A six-membered ring lactone (118) was isolated from
the water extracts of the soil fungus T. flavus [34]. Two
lactones (119 and 120) were isolated from an endophytic
fungus, a close relative of Talaromyces sp., found in
association with Cedrus deodara. They displayed a range
of cytotoxicities against human cancer cell lines (HCT-
116, A-549, HEP-1, THP-1, and PC-3), and induced
apoptosis in HL-60 cells, as evidenced by fluorescence and
scanning electron microscopy studies [35]. In the course of
screening for apoptosis inducers in ras dependent Ba/F3-
V12 cells, a new active compound, rasfonin (121) was
isolated from the fermented mycelium of Talaromyces sp.
3656-A1. The cytotoxic activity indicated that rasfonin
induced cell death in Ba/F3-V12 cells in an IL-3-free
medium containing Dex (2 9 10-7M) with an IC50 of
0.16 lg/mL and no cell death was observed in the presence
of IL-3 at concentrations less than 1.25 lg/mL of rasfonin
(IC501.8 lg/mL) [36].
Wortmannilactones E–H (122–125), from the culture of
the soil filamentous fungus T. wortmannii, showed inhibi-
tory activities against cathepsin B with IC50 values of 4.3,
6.5, 13.0, and 6.0 lM, respectively [37]. In screening for
NADH-fumarate reductase inhibitors led to the isolation of
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a new ukulactone analog, ukulactone C (126), as a major
polyene compound produced by Talaromyces sp. FKI-
6713. Ukulactone C possessed a potent inhibitory activity
(IC50 62 nM) against NADH-fumaratereductase of the
roundworm Ascaris suum invitro [38].
D-Glucono-1,4-lactone (127) was obtained from the
organic extracts of the soil fungus T. flavus [30]. A new
penicillic acid, coculnol (128) (five-membered ring lac-
tone), was produced by a coculture of Fusarium solani
FKI-6853 and Talaromyces sp. FKA-65. 128 showed an
inhibitory effect (with IC50 value of 283 lg/mL) against
A/PR/8/34 (H1N1) with weak cytotoxicity against MDCK
cells (IC50 value of 781 lg/mL) [39]. Berkedienolactone
(129) was isolated from the methanolic extracts of the
green Chinese onion-derived fungus T. pinophilus AF-02
[7]. A new spiculisporic acid derivative, spiculisporic acid
E (130), was isolated from the culture of the marine-sponge
associated fungus T. trachyspermus (KUFA 0021) [40].
The ethoxylated of spiculisporic acid E (131) was isolated
from the T. panasenkoi [41].
2.3 Polyketides
Polyketides, pyrones, xanthones, are both a major focus of
many research efforts and a rich source of novel metabo-
lites of Talaromyces.
Hydroxymethylmaltol (132) was isolated from the water
extracts of the soil fungus T. flavus [34]. Funicone (133)
and a new funicone derivative, 9,14-epoxy-11-deoxyfuni-
cone (134), were isolated from the strain T. flaus
IFM52668. As the results of the antifungal assay showed
that 133 had the characteristic inhibition against a human
pathogenic filamentous fungus, A. fumigates (11-mm
inhibition zone at 100 lg/disc), whereas 134 showed the
weak antifungal activity against A. niger (10-mm inhibition
zone at 200 lg/disc) [16]. Deoxyfunicone (135) and acto-
funicone (136) were obtained from the culture broth T.
flavus FKI-0076 which isolated from a soil sample. 135 and
136 showed no effect on the growth of Candida albicans
up to 300 lM, and a slight inhibition (35 %) was observed
at that concentration for NG-012. But in the absence of the
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funicones, the IC50 value of miconazole against C. albicans
was calculated to be 19 lM, however, in combination with
the funicones (50 lM), the IC50 values were decreased to
1.6–3.7 lM, demonstrating that they reinforced the inhi-
bition C. albicans activity of miconazole [20, 21].
Abenzopyrone derivate 137 was isolated from the
organic extracts of the soil fungus T. flavus [30]. Ben-
zopyrone derivatives 138 and 139 were isolated from a
culture broth of a fungus, Talaromyces sp. 138 exhibited
the weak anti-HBV activity with an IC50 value of 72.4 lM
[42].
Two xanthones, norlichexanthone (140) and seca-
lonic acid A (141), were obtained from the extract of
the mangrove endophytic fungus Talaromyces sp.
ZH-154 which was isolated from the stem bark of
Kandelia candel (L.) Druce, Rhizophoraceae. 141
exhibited high activities against six selected strains.
Moreover, in vitro cytotoxic activities indicated that
141 displayed very strong cytotoxicity against KB and
KBv200 cell lines with IC50 values of 0.63 and
1.05 lg/mL, closed to those of the positive control
(0.56 and 0.78 lg/mL). Whereas, the xanthone dimer
141 showed higher bioactivity than the xanthone
monomer 140 [43].
A new isopentenylxanthenone, talaroxanthenone (142),
was isolated from the culture broth and mycelia of a
marine fungus Talaromyces sp. strain LF458. 142 dis-
played potent acetylcholinesterase inhibitory activities
with IC501.61 lM. Interestingly, phosphodiesterase PDE-
4B2 was inhibited by compounds 142 (IC50 7.25 lM)
[26]. A new xanthone dimer talaroxanthone 143 was
isolated from Talaromyces sp. which collected in the
Amazonian rainforest from the medicinal plant Duguetia
stelechantha [44].
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Two newpolyketides, 7-epiaustdiol (144) and 8-O-
methylepiaustdiol (145), were obtained from the extract
of the mangrove endophytic fungus Talaromyces sp. ZH-
154 which was isolated from the stem bark of Kandelia
candel (L.) Druce, Rhizophoraceae. 144 showed signif-
icant inhibitory activity to Pseudomonas aeruginosa
with a MIC value of 6.25 lg/mL [43]. Two new
polyketides, TL-1 and -2 (luteusins A and B) (146 and
147) with monoamine oxidase (MAO) inhibitory effect
were isolated from an ascomycete T. lutcus [45]. Three
new azaphilones, luteusins C, D, and E (148–150),
together with 146 and 147, were isolated from an
Ascomycete, T. luteus. As regards MAO-inhibitory
activity, the IC50 values of 146 and 147 were 6.6 and
11 lM, respectively [46].
Kasanosins A (151) and B (152), novel azaphilones, were
isolated from cultures of Talaromyces sp. derived from the
seaweed. 151 and 152 selectively inhibited the activities of
eukaryotic DNA polymerases b and k (pols b and k) in
family X of pols, and 151 was a stronger inhibitor than 152,
and the IC50 values of 151 on rat pol b and human polk were
27.3 and 35.0 lM, respectively. And the results also sug-
gested that 151 and 152 could identify the inhibition between
pols b, k, and terminal deoxynucleotidyl transferase (TdT) in
family X [47]. Kasanosin C (153) and entonaemin A (154)
were isolated from the solid fermentation of Talaromyces sp.
T1BF derived from the old bast tissue of Taxus yunnanensis
[48]. A known polyketide (155) was isolated from the strain
T. wortmanii [49]. Deacetylisowortmin (156) was isolated
from the endophytic fungus T. wortmannii LGT-4 [50].
14 M.-M. Zhai et al.
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A new azaphilone derivative, monomethyl-(?)-mi-
torubrin (157), was isolated from the ascomata of T.
ardifaciens derived from the paddy soil from Bhaktapur,
Nepal [51]. Four new chlorinated azaphilones, helicusins
A–D (158–161), were isolated from T. helices. 158–161
showed weak MAO-inhibitory effects [52]. Diaza-
philonic acid (162) was obtained from T. flavus PF1195.
162 inhibited DNA amplification by polymerase chain
reaction (PCR) with Thermus thermophilus DNA poly-
merase and the IC50 value was 2.6 lg/mL. 162 dose-
dependently inhibited the telomerase activity of MT1
(human leukemia) and almost completely inhibited the
activity at 50 lM. But 162 showed no antimicrobial
activity [53].
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2.4 Quinones
Three pigments, emodin (163), x-hydroxyemodin (164),
and emodic acid (165), were obtained from the strain
T. avellaneus [54]. Emodin, erythroglaucin (166), and
catenarin (167), were isolated from the strain T. stipitatus
[55]. A new atropisomer, biemodin (168), as well as five
known metabolites (165 and 169–172), was isolated from
the strain T. wortmannii, an endophyte of Aloe vera. 169
and 171 exhibited considerable antibiotic activity against
Gram positive pathogenic bacteria with MIC values
ranging between 4 and 16 lg/mL. 168 also showed strong
activity against Gram positive bacteria, especially against
MRSA, but was less active compared to compounds 169
and 171 [49]. Emodin (163) and skyrin (169) were also
isolated from the extract of the mangrove endophytic
fungus Talaromyces sp. ZH-154 derived from Kandelia
candel (L.) Druce [43]. Skyrin (169) was also isolated
from the strain T. wortmannii, an endophyte of Aloe vera
[56].
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Two bisdihydroanthracenone atropodiastereomeric
pairs, homodimeric flavomannin A (173) and flavo-
mannin B (174), two new unsymmetrical dimers 175
and 176, and two new mixed dihydroanthracenone/an-
thraquinone dimers 177 and 178, were isolated from T.
wortmannii, an endophyte of Aloe vera. The compounds
exhibited antibacterial activity, including (multi) drug-
resistant clinical isolates and compounds 173–178 were
predominantly active against Staphylococci, with MIC
values from 4 to 8 lg/mL. Reporter gene analyses
indicated induction of the SOS response for some of the
derivatives, suggesting interference with DNA structure
or metabolism. But the compounds showed no cytotoxic
activity, encouraging their further evaluation as poten-
tial starting points for antibacterial drug development
[56].
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Two new tricyclic polyketides, vanitaracin A (179) and
B (180), were isolated from a culture broth of a fungus,
Talaromyces sp. 179 and 180 were evaluated for anti-HBV
activity using HBV-susceptible HepG2-hNTCP-C4 cells
and 179 exhibited the strong anti-HBV activity with an
IC50 value of 10.5 lM [42]. Stemphyperylenol (181) was
isolated from the extract of the mangrove endophytic
fungus Talaromyces sp. ZH-154, and showed inhibitory
activity against Sarcina ventriculi with a MIC value
of3.12 lg/mL, lower than that of ampicillin (12.5 lg/mL)
[43].
2.5 Steroids and Terpenoids
A steroid 182 was isolated from the genus of Talaromyces
sp. T1BF for the first time which isolated from an endo-
phyte from Taxus yunnanensis by chromatography tech-
niques [57]. A new natural product 3-acetyl ergosterol 5,8-
endoperoxide (183) was isolated from the culture of the
marine-sponge associated fungus T. trachyspermus (KUFA
0021) [40]. Secovironolide (184) was purified from the
culture broth of T. wortmanni and is the first example of a
furanosteroid scaffold bearing a five-membered B ring.
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Additional known viridian derivatives (185–188, 190) were
isolated, including the new epoxide containing compound,
epoxyvirone (189). Isolates were tested and showed only
weak MAO inhibitory activity [50].
A new nardosinane-type sesquiterpene, talaflavuterpenoid
A (191), was isolated from the wetland soil-derived fungus T.
flavus BYD07-13. 191 was tested for the cytotoxic activity
against five human tumor cell lines and the antimicrobial
activity, however, 191 showed no cytotoxic (IC50[ 40 lM)
and antimicrobial activities (MIC[ 1.0 mg/mL) [58]. Four
new norsesquiterpene peroxides, named talaperoxides A–D
(192–195), as well as a known analogue, steperoxide B (196),
had been isolated from a mangrove endophytic fungus, T.
flavus. Cytotoxic activities of 192–196were evaluated in vitro
against human cancer cell lines MCF-7, MDA-MB-435,
HepG2, HeLa, and PC-3.193 and 195 showed activity against
the five human cancer cell lines with IC50 values between 0.70
and 2.78 lg/mL [59].
2.6 Others
(-)-Epoformin(197) and (1S*,3R*,5R*)-3-methyl-2-oxa-
bicyclo[3.3.1]nonan-7-one (198) were isolated from an
endophytic fungus Talaromyces sp., found in associa-
tion with Cedrus deodara. The sulforhodamine B
cytotoxicity assay indicated that 197 was found to be
the most active followed by compound 198 [35]. Four
new spiroketaltalaromycins (199–202) had been isolated
from the strain T. stipitatus [60]. A new metabolite,
trachyspic acid (203) that inhibited heparanase, was
isolated from the culture broth of T. trachyspermus
SANK 12191. Its structure was determined from NMR
spectral analyses and chemical reactions as a tricar-
boxylic acid derivative containing a spiroketal. The IC50
value of trachyspic acid against heparanase was 36 lM
[61].
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A novel benzene derivative (204) was isolated from a
culture broth of a fungus, Talaromyces sp., and it was
evaluated for anti-HBV activity using HBV-susceptible
HepG2-hNTCP-C4 cells, but 204 exhibited the weak anti-
HBV activity [42]. 5-Hydroxymethylfurfural (205) and two
benzene derivatives 206 and 207 were isolated from the
organic extracts of the soil fungus T. flavus [30]. 207 was
also evaluated for its ability to inhibit HIV-1 integrase in
coupled and strand-transfer assays and the data indicated
that 207 with IC50 values of 19 lM in the coupled assay
and 25 lM in the strand-transfer assay [62]. Two benzene
derivatives 208 and 209 from the genus of Talaromyces sp.
T1BF which isolated from an endophyte from Taxus yun-
nanensis by chromatography techniques [57].
Three diphenyl ether derivatives including two new nat-
ural products, tenelates A (210) and B (211), together with
the known compound, tenellic acid C (212), were isolated
from the mangrove endophytic fungus Talaromyces sp.
(SBE-14), from the South China Sea [63]. Three new
derivatives of p-hydroxybenzoic acid (213–215) had been
isolated from the culture filtrate of T. derxii [64].
A new long-chain dicarboxylic acid, 2-hydroxyradiclonic
acid (216), and four known compounds, benzoic acid (217),
(Z)-3-phenyl propenal (218), 2-formyl-3,5-dihydroxy-4-
methylbenzoic acid (219), and radiclonic acid (220), were
isolated from the methanolic extracts of the green Chinese
onion-derived fungus T. pinophilus AF-02. 216 showed
significant antibacterial activities against E. coli [7].
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A new antibiotic, fosfonochlorin (221), was found in the
culture filtrate of four strains of fungi freshly isolated from
soil samples including T. flavus. The biological activity
indicated that it was active against Proteus mirabilis and P.
vulgaris and weakly active against Salmonella enteritidis,
Klebsiella pneumoniae and Providencia rettgeri, and its
synergistic effect with glucose-6-phosphate was observed
on Staphylococcus aureus and Escherichia coli [65].
A new antifungal antibiotic, named talaron, had been
isolated from the culture of T. vermiculatus (M-3224).
Talaron is water-soluble acidic polysaccharide containing
nitrogen and phosphorus, and its molecular weight was
estimated to be 7000–8000. Talaron had strong fungicidal
activity against filamentous dermatophytes and exhibited
inhibitory activity against the spore germination of Tri-
chophyto asteroides and showed cytotoxic effect at 1 mcg/
mL on HeLa cells, and at 0.2 mcg/mL on mouse embryo
fibroblast cells, but no antibacterial activity [66].
3 Conclusions
The Talaromyces genus includes many species with a
variety of uses, some of which are important in the food
products and agriculture. Since, several anthraquinone
metabolites from T. avellaneus were isolated in 1965 [54],
lots of secondary metabolites described in this report were
obtained from this genus fungi which from a soil sample,
from the plant, or from a marine sponge. The 221 com-
pounds, including 43 alkaloids and peptides, 88 esters, 31
polyketides, 19 quinones, 15 steroid and terpenoids, and 25
other structure compounds, described in this review were
isolated from 28 species, which 19 species have been
determined and 9 species were not given the specific names
(Table 1). The secondary metabolite studies were mainly
performed on the commonest species of the genus, T. flavus
[3]. The stereochemistry of many compounds was deter-
mined via circular dichroism spectrum [7], Mosher’s
analysis method [8], Marfey’s method [13], a single-crystal
X-ray diffraction experiment using Cu Ka radiation [59],
or quantum chemical calculation [6]. Those fungi were
cultivated with varying media: potato dextrose, barley
grains [10], rice [25], WSP30 [26], ISP2 broth [44], or other
modified medium.
In the early years of secondary metabolite of those genus
species research was less emphasis on biological testing,
but increasingly there has been a focus on the biological
properties of these compounds. Inhibitory activity to
tumour cells [17], bacteria [7], fungi [10], HBV [42],
nematode [8], HIV-1-integrase [62], caspase-3 [11], mos-
quito larval [14], 5-lipoxygenase [27], and other activities
were performed. Some of the isolated compounds have
been used as pigments.
Studies on total synthesis and biotransformation of some
of those compounds have been described. Structure–ac-
tivity relationships have also been undertaken. Recently,
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there has been great interest in the study of biosynthesis
genes based on secondary metabolites from the genus.
However, systematic secondary metabolites–biosynthesis
genes relationship might give insight into the molecular
level, seem to be absent. This might be a promising
direction in which work in the field of the secondary
constituents from this genus fungi may proceed.
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Table 1 The source of Talaromyces species
Species Source References
Talaromyces sp. [6], [36], [20], [22], [42], [33]
A soil sample [14], [32], [38], [39]




Kandelia candel [43], [63]
Taxus yunnanensis [48], [57]
Sand [42]
Seaweed [47]
T. ardifaciens Paddy soil [51]
T. avellaneus A Soil sample [54]
T. bacillosporus [24]
A soil sample [25]
T. convolutes [10]
T. derxii A soil sample [27], [29], [64]
T. flavus [53], [62], [16]
A soil sample [21], [30], [34], [65]
Wetland soil [19], [31], [58]
Leaves, Sonneratia apetala [59]
T. helices [52]
T. luteus [45], [46]
T. minioluteus A marine sponge [11]
T. panasenkoi [41]
T. pinophilus A soil sample [28]
Green Chinese onion [7]
T. stipitatus [55], [60]
T. tardifaciens Paddy soil [51]
T. thailandiasis A soil sample [12]
T. thermophilus Hot springs [4], [5], [8], [9]
T. trachyspermus Marine sponge Clathria reianwardii [40]
A soil sample [61]
T. vermiculatus [66]
T. verruculosus Rhizosphere soil of Stellera chamaejasme [15]
T. wortmannii A soil sample [17], [18], [37]
Plants, Aloe vera [13], [49], [56]
Plants, Tripterygium wilfordii [50]
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appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
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